Startup Atlas · Diagnostics
SN Genelab Acquired
Surat-based diagnostic genomics laboratory (FY26 turnover ₹57.96 Cr); Dr Lal PathLabs agreed in Sep 2026 to acquire 70% of it.
UndisclosedTotal funding (tracked)
0Funding rounds
—Last round
SN Genelab: Funding Rounds
No funding rounds tracked for SN Genelab yet.
Acquisitions
| Date | Acquirer | Acquired | Amount | Source |
|---|---|---|---|---|
| 24 Sep 2026 | Dr Lal PathLabs | SN Genelab | $17.52 Mn | source |
Recent Signals
-
24 Sep 2026 · ma-strategic
Dr Lal PathLabs takes majority stake in SN Genelab source
News on SN Genelab
No coverage of SN Genelab linked yet.
L Litmus · by Lapaas
Got an idea like this one? Validate it with the same 9-block framework, free.
Start Free ValidationFAQs on SN Genelab
What does SN Genelab do?
Surat-based diagnostic genomics laboratory (FY26 turnover ₹57.96 Cr); Dr Lal PathLabs agreed in Sep 2026 to acquire 70% of it.
Where is SN Genelab headquartered?
SN Genelab is headquartered in Surat, Gujarat, India.
Sources & corrections.
Every fact on this page is compiled from cited public sources — follow the "source" links beside each entry. Profile sources: www.tofler.in www.freepressjournal.in · Last verified 21 Oct 2026. · Report a correction